ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen research firms that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […]
More Stories
Russia Will Help China Advance Submarine Technology, US Indo-Pacific Commander Says
By Frank Fang In return for China’s support during its war on Ukraine, Russia will likely assist Beijing to advance...
Financial Contrast: Carnival Co. & (NYSE:CUK) versus Viking (NYSE:VIK)
Viking (NYSE:VIK – Get Free Report) and Carnival Co. & (NYSE:CUK – Get Free Report) are both transportation companies, but...
Centaurus Financial Inc. Lowers Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Centaurus Financial Inc. cut its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 2.5%...
PepsiCo, Inc. (NASDAQ:PEP) Shares Purchased by Summit Trail Advisors LLC
Summit Trail Advisors LLC increased its position in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 18.3% during the...
Costco Wholesale Co. (NASDAQ:COST) Shares Acquired by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. boosted its stake in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 19.0% in the third...
SevenBridge Financial Group LLC Buys 335 Shares of Chevron Co. (NYSE:CVX)
SevenBridge Financial Group LLC grew its stake in Chevron Co. (NYSE:CVX – Free Report) by 3.3% in the third quarter,...